CD44 and colonic neoplasm: Yang et al. utilized a copolymer commonly used in drug delivery, Poly (lactic-co-glycolic acid) (PLGA), along with hyaluronic acid (HA) to prepare HA-coated PLGA nanoparticles that are specific for CD44 receptors on colon cancer cells with high CD44 expression.